EP2086317A4 - Nicotine formulations, kits and systems and methods for their use - Google Patents
Nicotine formulations, kits and systems and methods for their useInfo
- Publication number
- EP2086317A4 EP2086317A4 EP07867591A EP07867591A EP2086317A4 EP 2086317 A4 EP2086317 A4 EP 2086317A4 EP 07867591 A EP07867591 A EP 07867591A EP 07867591 A EP07867591 A EP 07867591A EP 2086317 A4 EP2086317 A4 EP 2086317A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- kits
- systems
- methods
- nicotine formulations
- nicotine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Addiction (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86823806P | 2006-12-01 | 2006-12-01 | |
US91104407P | 2007-04-10 | 2007-04-10 | |
US91318507P | 2007-04-20 | 2007-04-20 | |
US91651007P | 2007-05-07 | 2007-05-07 | |
US91719007P | 2007-05-10 | 2007-05-10 | |
US98207007P | 2007-10-23 | 2007-10-23 | |
US11/932,402 US20080138294A1 (en) | 1999-07-16 | 2007-10-31 | Systems and methods for effecting cessation of tobacco use |
US11/931,921 US20080138399A1 (en) | 1999-07-16 | 2007-10-31 | Dual release nicotine formulations, and systems and methods for their use |
US11/932,437 US8256433B2 (en) | 1999-07-16 | 2007-10-31 | Systems and methods for effecting cessation of tobacco use |
US11/931,867 US20080138398A1 (en) | 1999-07-16 | 2007-10-31 | Dual release nicotine formulations, and systems and methods for their use |
PCT/US2007/024636 WO2008069970A2 (en) | 2006-12-01 | 2007-11-30 | Nicotine formulations, kits and systems and methods for their use |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2086317A2 EP2086317A2 (en) | 2009-08-12 |
EP2086317A4 true EP2086317A4 (en) | 2010-03-03 |
Family
ID=39492806
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP07867591A Withdrawn EP2086317A4 (en) | 2006-12-01 | 2007-11-30 | Nicotine formulations, kits and systems and methods for their use |
EP07867592A Withdrawn EP2086527A4 (en) | 2006-12-01 | 2007-11-30 | Systems for effecting cessation of tobacco use |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP07867592A Withdrawn EP2086527A4 (en) | 2006-12-01 | 2007-11-30 | Systems for effecting cessation of tobacco use |
Country Status (2)
Country | Link |
---|---|
EP (2) | EP2086317A4 (en) |
WO (2) | WO2008069972A2 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
JP5254616B2 (en) | 2004-09-13 | 2013-08-07 | クロノ セラピューティクス、インコーポレイテッド | Biosynchronous transdermal drug delivery |
EP2395974B1 (en) * | 2009-02-11 | 2016-09-07 | Heglund, a.s. | A composition for buccal absorption of nicotine for the purpose of smoking cessation |
WO2011023796A1 (en) * | 2009-08-31 | 2011-03-03 | Abbott Healthcare Products B.V. | Bifeprunox for treating addiction |
TWI484958B (en) * | 2011-05-19 | 2015-05-21 | Heglund A S | A composition for buccal absorption of nicotine for the purpose of smoking cessation |
CA2841785A1 (en) | 2011-07-06 | 2013-01-10 | The Parkinson's Institute | Compositions and methods for treatment of symptoms in parkinson's disease patients |
RU2541312C2 (en) * | 2011-08-31 | 2015-02-10 | Александр Васильевич Иващенко | Pharmaceutical composition, method for preparing and device for using it |
US10556011B2 (en) | 2011-12-02 | 2020-02-11 | Joshua D. Levine | Method and system for adding sensory conditioning cues in a pharmacotherapeutic regimen |
US10034988B2 (en) | 2012-11-28 | 2018-07-31 | Fontem Holdings I B.V. | Methods and devices for compound delivery |
US10194693B2 (en) | 2013-09-20 | 2019-02-05 | Fontem Holdings 1 B.V. | Aerosol generating device |
CA2974324A1 (en) | 2015-01-28 | 2016-08-04 | Zita S. Netzel | Drug delivery methods and systems |
EP3267875A4 (en) | 2015-03-12 | 2018-12-05 | Chrono Therapeutics Inc. | Craving input and support system |
US10149844B2 (en) | 2015-09-16 | 2018-12-11 | Philip Morris Products S.A. | Inhalable nicotine formulations, and methods of making and using thereof |
US11224594B2 (en) | 2015-09-16 | 2022-01-18 | Philip Morris Products S.A. | Nicotine formulations and methods of making and using the same |
US9585835B1 (en) * | 2015-09-16 | 2017-03-07 | Sansa Corporation (Barbados) Inc. | Inhalable nicotine formulations and methods of making and using the same |
US20170071248A1 (en) | 2015-09-16 | 2017-03-16 | Sansa Corporation (Barbados) Inc. | System and Method for Controlling the Harshness of Nicotine-Based Dry Powder Formulations |
WO2018129304A1 (en) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
MX2019010263A (en) * | 2017-03-07 | 2019-10-09 | Philip Morris Products Sa | Inhalable nicotine formulations, and methods of making and using thereof. |
AU2019279884A1 (en) | 2018-05-29 | 2020-12-10 | Morningside Venture Investments Limited | Drug delivery methods and systems |
GB201817863D0 (en) * | 2018-11-01 | 2018-12-19 | Nicoventures Trading Ltd | Aerosolisable formulation |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994027576A1 (en) * | 1993-05-20 | 1994-12-08 | Danbiosyst Uk Limited | Nasal drug delivery composition containing nicotine |
WO2001005459A1 (en) * | 1999-07-16 | 2001-01-25 | Aradigm Corporation | System for effecting smoke cessation |
WO2003097146A1 (en) * | 2002-05-15 | 2003-11-27 | Aradigm Corporation | System for effecting smoke cessation |
US20040037879A1 (en) * | 2001-11-02 | 2004-02-26 | Adusumilli Prasad S. | Oral controlled release forms useful for reducing or preventing nicotine cravings |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2097443T3 (en) * | 1992-02-20 | 1997-04-01 | Wielligh Johannes Louw Kot Von | PRODUCT TO HELP SMOKERS TO ABANDON THE HABIT. |
US6024097A (en) * | 1992-02-20 | 2000-02-15 | J Mom Trust | Product for assisting a smoker in giving up the habit |
US5362496A (en) * | 1993-08-04 | 1994-11-08 | Pharmetrix Corporation | Method and therapeutic system for smoking cessation |
US5810018A (en) * | 1994-12-29 | 1998-09-22 | Monte; Woodrow C. | Method, composition and apparatus for reducing the incidence of cigarette smoking |
US20070100000A1 (en) * | 2000-11-01 | 2007-05-03 | Epstein Mel H | Methods of providing neuroprotection |
US6759435B1 (en) * | 2003-07-03 | 2004-07-06 | A.P. Group Inc. | Antidepressant drugs and methods |
-
2007
- 2007-11-30 EP EP07867591A patent/EP2086317A4/en not_active Withdrawn
- 2007-11-30 WO PCT/US2007/024641 patent/WO2008069972A2/en active Application Filing
- 2007-11-30 WO PCT/US2007/024636 patent/WO2008069970A2/en active Application Filing
- 2007-11-30 EP EP07867592A patent/EP2086527A4/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994027576A1 (en) * | 1993-05-20 | 1994-12-08 | Danbiosyst Uk Limited | Nasal drug delivery composition containing nicotine |
WO2001005459A1 (en) * | 1999-07-16 | 2001-01-25 | Aradigm Corporation | System for effecting smoke cessation |
US20040037879A1 (en) * | 2001-11-02 | 2004-02-26 | Adusumilli Prasad S. | Oral controlled release forms useful for reducing or preventing nicotine cravings |
WO2003097146A1 (en) * | 2002-05-15 | 2003-11-27 | Aradigm Corporation | System for effecting smoke cessation |
Also Published As
Publication number | Publication date |
---|---|
WO2008069970A2 (en) | 2008-06-12 |
WO2008069970A3 (en) | 2008-10-16 |
WO2008069972A3 (en) | 2008-10-30 |
EP2086527A2 (en) | 2009-08-12 |
EP2086527A4 (en) | 2010-03-03 |
EP2086317A2 (en) | 2009-08-12 |
WO2008069972A2 (en) | 2008-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2086317A4 (en) | Nicotine formulations, kits and systems and methods for their use | |
GB2474599B (en) | Multi-zone, single trip well completion system and methods of use | |
TWI347760B (en) | Methods, apparatus, and system for venue-cast | |
AU2007275047A8 (en) | Compositions and methods for vaccinating against HSV-2 | |
EP2043647A4 (en) | Controlled release formulations and associated methods | |
GB2443930B (en) | Amplifier | |
EP1986702A4 (en) | Hyperpolarization methods, systems and compositions | |
EP1853696A4 (en) | Electro-blotting devices, systems, and kits, and methods for their use | |
EP1850755A4 (en) | Devices, systems and methods for plaque type determination | |
IL201303A0 (en) | Compositions, devices, systems, and methods for using a nanopore | |
EP2151500A4 (en) | Branched -glucan, -glucosyltransferase producing the same, method for producing the same and use thereof | |
EP2005625A4 (en) | Methods, systems, and apparatus for multi-purpose metering | |
IL197284A0 (en) | Disinfectant systems and methods | |
HK1121757A1 (en) | Pyrroloazacyclic derivatives, preparing method and use thereof | |
GB0616111D0 (en) | Agents, methods and uses | |
PL1988090T3 (en) | Imidazol-5-carboxylic acid derivatives, preparation methods and use therrof | |
EP2164991A4 (en) | Methods, systems, and kits for evaluating multiple sclerosis | |
HUP0500921A2 (en) | Tetrazole derivatives, process for their preparation and their use | |
IL196851A0 (en) | Systems and methods for using an http-aware client agent | |
EP2191431A4 (en) | Methods and systems for trading options and other derivatives | |
GB0719592D0 (en) | Compound, use and method | |
ZA200903049B (en) | Polymer-linked-bisphosphonate inhalant formulations and methods for using the same | |
TWI366746B (en) | Lithography system and lithography method using the same | |
HK1120837A1 (en) | Elastic interlining, method for its manufacture and use | |
GB0620930D0 (en) | Composition and method for use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20090529 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: GONDA, IGOR |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20100203 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/135 20060101AFI20100128BHEP Ipc: A61P 25/34 20060101ALI20100128BHEP Ipc: A61K 31/465 20060101ALI20100128BHEP |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20100503 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20110708 |